Rudge Geordie, Barrett Simon P, Scott Bernadette, van Driel Ian R
Department of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Australia.
J Immunol. 2007 Apr 1;178(7):4089-96. doi: 10.4049/jimmunol.178.7.4089.
Depletion of CD4+CD25+Foxp3+ regulatory T cells (CD25+ T(reg)) with an anti-CD25 Ab results in immune-mediated rejection of tolerogenic solid tumors. In this study, we have examined the immune response to a mesothelioma tumor in mice after depletion of CD25+ cells to elucidate the cellular mechanisms of CD25+ T(reg), a subject over which there is currently much conjecture. Tumor rejection was found to be primarily due to the action of CD8+ T cells, although CD4+ cells appeared to play some role. Depletion of CD25+ cells resulted in an accumulation in tumor tissue of CD4+ and CD8+ T cells and NK cells that were producing the potent antitumor cytokine IFN-gamma. Invasion of tumors by CD8+ T cells was partially dependent on the presence of CD4+ T cells. Although a significant increase in the proliferation and number of tumor-specific CD8+ T cells was observed in lymph nodes draining the tumor of anti-CD25-treated mice, this effect was relatively modest compared with the large increase in IFN-gamma-producing T cells found in tumor tissue, which suggests that the migration of T cells into tumor tissue may also have been altered. Depletion of CD25+ cells did not appear to modulate antitumor CTL activity on a per cell basis. Our data suggests that CD25+ T(reg) limit the accumulation of activated T cells producing IFN-gamma in the tumor tissue and, to a lesser extent, activation and/or rate of mitosis of tumor-specific T cells in lymph nodes.
用抗CD25抗体清除CD4 + CD25 + Foxp3 +调节性T细胞(CD25 + T(reg))会导致免疫介导的耐受性实体瘤排斥反应。在本研究中,我们检测了清除CD25 +细胞后小鼠对间皮瘤肿瘤的免疫反应,以阐明CD25 + T(reg)的细胞机制,目前对此主题存在诸多推测。发现肿瘤排斥主要是由于CD8 + T细胞的作用,尽管CD4 +细胞似乎也发挥了一些作用。清除CD25 +细胞导致肿瘤组织中产生强效抗肿瘤细胞因子IFN-γ的CD4 +和CD8 + T细胞以及NK细胞积聚。CD8 + T细胞对肿瘤的侵袭部分依赖于CD4 + T细胞的存在。尽管在抗CD25治疗小鼠的肿瘤引流淋巴结中观察到肿瘤特异性CD8 + T细胞的增殖和数量显著增加,但与肿瘤组织中产生IFN-γ的T细胞的大量增加相比,这种效应相对较小,这表明T细胞向肿瘤组织的迁移也可能发生了改变。清除CD25 +细胞似乎并未在单个细胞基础上调节抗肿瘤CTL活性。我们的数据表明,CD25 + T(reg)限制了肿瘤组织中产生IFN-γ的活化T细胞的积聚,并在较小程度上限制了淋巴结中肿瘤特异性T细胞的活化和/或有丝分裂率。